Dealing with Disruption: Lessons from a Disruptive Innovator

David Paul grew Globus Medical to a $5 billion market cap with disruptive innovations - here's how you can disrupt or react to disruption.
Who: 
David Paul, Founder and Chairman, Globus Medical Inc.
When: 
Monday September 23, 2019 5:30pm7:30pm
Where: 
Temple University Main Campus

Innovation and adaptation have become imperatives for today's companies and entrepreneurs, but what does that mean in practice? The Innovation Leaders Speaker Series, presented in partnership by the Fox School of Business at Temple University and the Innovation Research Interchange, addresses the intersection between innovation and entrepreneurship, and features leaders in the field who have successfully put these principles into practice at organizations of all sizes and industries.

About David Paul:

Temple alumnus David Paul founded Globus Medical in 2003 and served as its Chief Executive Officer until August 2017, when he transitioned into the role of Executive Chairman. Prior to founding Globus, which he took public in 2012, Mr. Paul was employed at medical device company Synthes in various positions. He most recently served as Director of Product Development for Synthes, where he was responsible for product development and marketing functions. Prior to Synthes, Mr. Paul worked as a Research Engineer in biomaterials research at Temple University. Mr. Paul is a named inventor on approximately 45 patents and 74 pending patent applications. He received a B.S. in Mechanical Engineering from the University of Madras, and an M.S. in Computer Integrated Mechanical Engineering Systems from Temple University.

Register here